What Has Impacted Hexo (TSX:HEXO) Stock Recently?

A look at price movements for Hexo Corp. (TSX:HEXO)(NYSE:HEXO) stock in September 2019.

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Shares of Canada-based cannabis company Hexo (TSX:HEXO)(NYSE:HEXO) have gained 10% since the start of this month. However, the stock has been quite volatile in September 2019.

Hexo shares rose 14% in the first four trading days, as it seemed that cannabis stocks had bottomed out and would begin moving higher. But, unimpressive results from marijuana giant Aurora Cannabis sent several stocks lower in the last week. The suspension notice sent to CannTrust did not help either.

Hexo stock then fell over 14% in the last week before rising close to 11.5% on Friday.

Analyst begins coverage on Hexo stock?

Hexo shares rose by double digits on September 20 after MKM analyst Bill Kirk began coverage on the stock. Kirk has a “buy” recommendation for Hexo with a 12-month price target of $11.5.

Hexo closed trading at $5.84 on Friday and rose 1% yesterday. It is currently trading 43% above its 52-week low and 47% below its 52-week high.

Kirk expects Hexo’s strategic initiatives and partnerships with companies outside the cannabis sector, such as the one with Molson Coors to hold it in good stead. Further, Hexo also stated that it is in talks to partner with 60 other Fortune 500 companies.

According to Kirk, Hexo sales with touch $400 million by end of fiscal 2020 (ending in July) driven by these partnerships. This is more than current analyst revenue estimates of $329.5 million for fiscal 2020. Analysts have a 12-month average target price of $10.36, which is 77% higher than the current price.

Upcoming legalization should drive prices higher

We have seen cannabis stocks reach record highs when recreational use was legalized in Canada last October. Now investors will be hoping the next wave of legalization will drive shares higher. Similar to peer companies, Hexo is set to benefit as edibles, vapes, and concentrates hit the shelves by end of 2019.

Hexo has a product portfolio that includes cannabis flowers, pre-rolls, and oils. It aims to become the top-branded Ingredients for Foods cannabis company in the world. Hexo wants to build a strong portfolio of consumer-centric brands.

However, this might be easier said than done. Retail or even online buyers are not brand conscious. A lot of them are, in fact, brand neutral and are loyal to the neighborhood retail store instead. Will edibles legalization help cannabis companies create a base of brand loyalists?

The verdict

We know the global cannabis market is set to grow at a robust rate. Hexo is looking for revenue growth in Europe and Latin America to drive sales in upcoming quarters. One of the company’s goals is to be a top three player in terms of market share where its products are sold.

A major driver for Hexo’s stock growth is its focus on profitability. While Aurora, Canopy Growth, and many other players are struggling with low margins and high operational costs, Hexo is estimated to post an adjusted profit in 2020.

While Hexo’s earnings growth in fiscal 2019 (ended in July) will be flat, the company is expected to grow its bottom line by 170.6% in fiscal 2020. Compare this growth to Hexo’s forward price-to-earnings multiple of 48, and we can see that the stock is undervalued.

Hexo stock should continue to move higher in the coming months, but a lot will depend on its fourth-quarter results, which are likely to be announced next month.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »